St. Andrews, United Kingdom

Greg Mann

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: University Court of the University of St. Andrews, University of Aberdeen. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Greg Mann. Retrieved from https://idiyas.com/inventor/greg-mann

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Greg Mann

Introduction

Greg Mann is an accomplished inventor based in St. Andrews, GB. He holds a patent for a significant innovation in the field of biotechnology and chemical synthesis. His work has the potential to impact various applications in these industries.

Latest Patents

Mann's notable patent is for a "Modified heterocyclase." This invention relates to an engineered leader-independent heterocyclase, also known as a cyclodehydratase. It comprises a defined cyanobactin leader sequence that drives the efficient conversion of heterocyclisable amino acids, such as Ser, Thr, and Cys, within a peptide substrate lacking a leader sequence into heterocycles. This process produces a homogenous heterocycle-containing product, which may be useful in biotechnology and chemical synthesis.

Career Highlights

Throughout his career, Greg Mann has worked with prestigious institutions, including the University Court of the University of Aberdeen and the University Court of the University of St. Andrews. His contributions to these organizations have been instrumental in advancing research and innovation in his field.

Collaborations

Mann has collaborated with notable individuals such as James Naismith and Jesko Koehnke. These partnerships have further enriched his work and expanded the impact of his inventions.

Conclusion

Greg Mann's innovative contributions, particularly his patent for the modified heterocyclase, highlight his significant role in the fields of biotechnology and chemical synthesis. His work continues to pave the way for advancements in these areas.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…